Laura Sierra

617 total citations
10 papers, 137 citations indexed

About

Laura Sierra is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, Laura Sierra has authored 10 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 2 papers in Rheumatology. Recurrent topics in Laura Sierra's work include Sarcoma Diagnosis and Treatment (4 papers), Cancer-related gene regulation (4 papers) and Protein Degradation and Inhibitors (3 papers). Laura Sierra is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Cancer-related gene regulation (4 papers) and Protein Degradation and Inhibitors (3 papers). Laura Sierra collaborates with scholars based in United States, France and United Kingdom. Laura Sierra's co-authors include Abha A. Gupta, Patrick Schöffski, Anand Rajarethinam, Jason T. Yustein, Víctor M. Villalobos, Mark Agulnik, Lyazat Kurenbekova, Tom Wei‐Wu Chen, Mrinal M. Gounder and Silvia Stacchiotti and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Laura Sierra

10 papers receiving 136 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Sierra United States 6 73 53 51 19 14 10 137
Quentin Campbell‐Hewson United Kingdom 5 33 0.5× 54 1.0× 56 1.1× 13 0.7× 14 1.0× 13 101
Anand Rajarethinam United States 5 54 0.7× 46 0.9× 51 1.0× 32 1.7× 6 0.4× 8 110
Gino Brunori United Kingdom 2 65 0.9× 40 0.8× 11 0.2× 10 0.5× 9 0.6× 4 130
Kayleen Bailey United States 5 79 1.1× 31 0.6× 29 0.6× 8 0.4× 4 0.3× 10 136
Karen Ouyang United States 7 113 1.5× 35 0.7× 33 0.6× 36 1.9× 8 0.6× 17 244
S. Adriaansz Netherlands 6 47 0.6× 34 0.6× 106 2.1× 18 0.9× 4 0.3× 8 168
Haojun Ouyang United States 5 48 0.7× 41 0.8× 64 1.3× 19 1.0× 6 0.4× 15 137
Rebeca Alba Rubío Germany 6 70 1.0× 49 0.9× 67 1.3× 19 1.0× 13 0.9× 10 160
J.J. Soto Castillo Spain 4 50 0.7× 27 0.5× 38 0.7× 11 0.6× 3 0.2× 14 103
Elizabeth A. Sellars United States 9 120 1.6× 16 0.3× 14 0.3× 8 0.4× 20 1.4× 14 214

Countries citing papers authored by Laura Sierra

Since Specialization
Citations

This map shows the geographic impact of Laura Sierra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Sierra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Sierra more than expected).

Fields of papers citing papers by Laura Sierra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Sierra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Sierra. The network helps show where Laura Sierra may publish in the future.

Co-authorship network of co-authors of Laura Sierra

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Sierra. A scholar is included among the top collaborators of Laura Sierra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Sierra. Laura Sierra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Merdad, Anas, Laura Sierra, Faraj Kargoli, et al.. (2024). Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement. JACC: Cardiovascular Interventions. 17(4). 552–560. 8 indexed citations
2.
Sierra, Laura, Leonhard Binzenhöfer, Hendrik Schulze‐Koops, et al.. (2023). A patient with Takayasu arteritis presenting with malignant hypertension: a case report. European Heart Journal - Case Reports. 7(6). ytad263–ytad263. 1 indexed citations
3.
Sierra, Laura, Ryan L. Shuck, Lyazat Kurenbekova, et al.. (2021). p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma. Oncogene. 40(6). 1176–1190. 12 indexed citations
4.
Sierra, Laura, Lyazat Kurenbekova, Ryan L. Shuck, et al.. (2020). Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma. Cancer Research. 81(1). 199–212. 29 indexed citations
5.
Sen, Shiraj, Meredith McKean, Laura Sierra, et al.. (2020). A phase Ib/III randomized, double-blind, placebo-controlled study of tazemetostat plus doxorubicin as frontline therapy for patients with advanced epithelioid sarcoma.. Journal of Clinical Oncology. 38(15_suppl). TPS11573–TPS11573. 5 indexed citations
6.
Chi, Susan, Franck Bourdeaut, Theodore W. Laetsch, et al.. (2020). Phase I study of tazemetostat, an enhancer of zeste homolog-2 inhibitor, in pediatric pts with relapsed/refractory integrase interactor 1-negative tumors.. Journal of Clinical Oncology. 38(15_suppl). 10525–10525. 22 indexed citations
7.
Gounder, Mrinal M., Silvia Stacchiotti, Patrick Schöffski, et al.. (2020). Efficacy, safety, and immune priming effect of tazemetostat in patients with epithelioid sarcoma.. Journal of Clinical Oncology. 38(15_suppl). 11564–11564. 2 indexed citations
8.
Stacchiotti, Silvia, Patrick Schöffski, Robin L. Jones, et al.. (2019). Safety and efficacy of tazemetostat, a first-in-class EZH2 inhibitor, in patients (pts) with epithelioid sarcoma (ES) (NCT02601950).. Journal of Clinical Oncology. 37(15_suppl). 11003–11003. 48 indexed citations
9.
Sierra, Laura, et al.. (2016). Comparative Approaches to Teaching Family Theory. 21(1). 1 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quentin Campbell‐Hewson Breakdown of academic impact, for papers by Anand Rajarethinam Breakdown of academic impact, for papers by Gino Brunori Breakdown of academic impact, for papers by Kayleen Bailey Breakdown of academic impact, for papers by Karen Ouyang Breakdown of academic impact, for papers by S. Adriaansz Breakdown of academic impact, for papers by Haojun Ouyang Breakdown of academic impact, for papers by Rebeca Alba Rubío Breakdown of academic impact, for papers by J.J. Soto Castillo Breakdown of academic impact, for papers by Elizabeth A. Sellars
Rankless by CCL
2026